Gene-class analysis of expression patterns induced by psychoactive pharmaceutical exposure in fathead minnow (Pimephales promelas) indicates induction of neuronal systems.
暂无分享,去创建一个
[1] Andrew J. Copp,et al. Genetics of human neural tube defects , 2009, Human molecular genetics.
[2] K Kümmerer,et al. Biodegradability of some antibiotics, elimination of the genotoxicity and affection of wastewater bacteria in a simple test. , 2000, Chemosphere.
[3] K. Swoboda,et al. Diagnosis and treatment of neurotransmitter-related disorders. , 2002, Neurologic clinics.
[4] E. Hattori,et al. Replication study of Japanese cohorts supports the role of STX1A in autism susceptibility , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[5] A. Sequeira,et al. Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression , 2009, Molecular Psychiatry.
[6] Princess E. Osei-Bonsu,et al. Neural Representation of Object Approach in a Decision-Making Motor Circuit , 2006, The Journal of Neuroscience.
[7] T. Snell,et al. Gene Expression Profiling in Ecotoxicology , 2003, Ecotoxicology.
[8] E. Nestler,et al. A molecular and cellular theory of depression. , 1997, Archives of general psychiatry.
[9] C. Richter,et al. Use of a 15 k gene microarray to determine gene expression changes in response to acute and chronic methylmercury exposure in the fathead minnow Pimephales promelas Rafinesque , 2008 .
[10] E. Thurman,et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. , 2002 .
[11] Vahram Haroutunian,et al. Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: A gene ontology study , 2005, Schizophrenia Research.
[12] S. Mori,et al. Postnatal development of locomotor movements in normal and para-chlorophenylalanine-treated newborn rats , 1995, Neuroscience Research.
[13] Alden K Henderson,et al. Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant. , 2004, The Science of the total environment.
[14] Jeanne Garric,et al. Human pharmaceuticals in surface waters. Implementation of a prioritization methodology and application to the French situation. , 2008, Toxicology letters.
[15] Kathryn N North,et al. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1 , 2005, Neurology.
[16] S. Watson,et al. Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia , 2004, Biological Psychiatry.
[17] G. Griebel,et al. Differential modulation of antipredator defensive behavior in Swiss-Webster mice following acute or chronic administration of imipramine and fluoxetine , 1995, Psychopharmacology.
[18] Michael Shannon,et al. The serotonin syndrome. , 2005, The New England journal of medicine.
[19] G. Gibson. Microarrays in ecology and evolution: a preview , 2002, Molecular ecology.
[20] B. Källén. Fluoxetine use in early pregnancy. , 2004, Birth defects research. Part B, Developmental and reproductive toxicology.
[21] Masanori Seki,et al. Life‐cycle toxicity of 4‐nonylphenol to medaka (Oryzias latipes) , 2001, Environmental toxicology and chemistry.
[22] D. Weber. Dose-dependent effects of developmental mercury exposure on C-start escape responses of larval zebrafish Danio rerio , 2006 .
[23] Y. Valcárcel,et al. Pollution by psychoactive pharmaceuticals in the Rivers of Madrid metropolitan area (Spain). , 2010, Environment international.
[24] O. Schoor,et al. Effects of Imatinib on Monocyte-Derived Dendritic Cells Are Mediated by Inhibition of Nuclear Factor-κB and Akt Signaling Pathways , 2005, Clinical Cancer Research.
[25] S. Mori,et al. Prenatal administration of para-chlorophenylalanine results in suppression of serotonergic system and disturbance of swimming movements in newborn rats , 1998, Neuroscience Research.
[26] K. Armbrust,et al. Laboratory persistence and fate of fluoxetine in aquatic environments , 2006, Environmental toxicology and chemistry.
[27] Reinhard Jahn,et al. Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 Å resolution , 1998, Nature.
[28] B. Källén. Neonate characteristics after maternal use of antidepressants in late pregnancy. , 2004, Archives of pediatrics & adolescent medicine.
[29] T. Jessell. Neuronal specification in the spinal cord: inductive signals and transcriptional codes , 2000, Nature Reviews Genetics.
[30] Mark K. Bennett,et al. A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion , 1993, Cell.
[31] J. Lazorchak,et al. Analysis of ecologically relevant pharmaceuticals in wastewater and surface water using selective solid-phase extraction and UPLC-MS/MS. , 2008, Analytical chemistry.
[32] J. Tarazona,et al. Occurrence of pharmaceutically active compounds in surface waters of the Henares-Jarama-Tajo River system (Madrid, Spain) and a potential risk characterization. , 2010, The Science of the total environment.
[33] Silvio Morato,et al. Measuring anxiety in zebrafish: A critical review , 2010, Behavioural Brain Research.
[34] E. Ayanoglu,et al. Drug-induced changes in P450 enzyme expression at the gene expression level: A new dimension to the analysis of drug–drug interactions , 2006, Xenobiotica; the fate of foreign compounds in biological systems.
[35] R. Skalko,et al. Movement disorders and neurochemical changes in zebrafish larvae after bath exposure to fluoxetine (PROZAC). , 2007, Neurotoxicology and teratology.
[36] David N. Reznick,et al. Do faster starts increase the probability of evading predators , 2005 .
[37] Giorgio Valle,et al. The Gene Ontology in 2010: extensions and refinements , 2009, Nucleic Acids Res..
[38] C. Delerue-Matos,et al. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. , 2010, Journal of hazardous materials.
[39] F. Lohoff. Genetic variants in the vesicular monoamine transporter 1 (VMAT1/SLC18A1) and neuropsychiatric disorders. , 2010, Methods in molecular biology.
[40] V. Cunningham,et al. Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment. , 2009, Regulatory toxicology and pharmacology : RTP.
[41] R. C. Eaton,et al. The Mauthner cell and other identified neurons of the brainstem escape network of fish , 2001, Progress in Neurobiology.
[42] Kriston L. McGary,et al. Systematic discovery of nonobvious human disease models through orthologous phenotypes , 2010, Proceedings of the National Academy of Sciences.
[43] S. Offermanns,et al. The semaphorin 4D‐plexin‐B signalLing complex regulates dendritic and axonal complexity in developing neurons via diverse pathways , 2009, The European journal of neuroscience.
[44] Heuiju Chun,et al. A generalized false discovery rate in microarray studies , 2011, Comput. Stat. Data Anal..
[45] G. Vallortigara,et al. Complementary left and right eye use during predator inspection and shoal‐mate scrutiny in minnows , 2002 .
[46] Zaharie Moldovan,et al. Environmental exposure of pharmaceuticals and musk fragrances in the Somes River before and after upgrading the municipal wastewater treatment plant Cluj-Napoca, Romania , 2009, Environmental science and pollution research international.
[47] C. Tyler,et al. Pharmaceuticals in the aquatic environment: A critical review of the evidence for health effects in fish , 2010, Critical reviews in toxicology.
[48] C. Metcalfe,et al. Pharmaceuticals and Endocrine Disruptors in Wastewater Treatment Effluents and in the Water Supply System of Calgary, Alberta, Canada , 2006 .
[49] Robert Gerlai,et al. Zebrafish antipredatory responses: A future for translational research? , 2010, Behavioural Brain Research.
[50] S. Jørgensen,et al. Occurrence, fate and effects of pharmaceutical substances in the environment--a review. , 1998, Chemosphere.
[51] G. Vallortigara. Comparative Neuropsychology of the Dual Brain: A Stroll through Animals' Left and Right Perceptual Worlds , 2000, Brain and Language.
[52] D. Guilloteau,et al. Fetal exposure to teratogens: Evidence of genes involved in autism , 2011, Neuroscience & Biobehavioral Reviews.
[53] E. Furlong,et al. Trace analysis of antidepressant pharmaceuticals and their select degradates in aquatic matrixes by LC/ESI/MS/MS. , 2008, Analytical chemistry.
[54] K. Jones,et al. Birth outcomes in pregnant women taking fluoxetine. , 1996, The New England journal of medicine.
[55] Michael A. Thomas,et al. Gene set enrichment analysis of microarray data from Pimephales promelas (Rafinesque), a non-mammalian model organism , 2011, BMC Genomics.
[56] H. Hoyme,et al. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. , 2003, The Journal of pediatrics.
[57] Terje Sagvolden,et al. A comparison of molecular alterations in environmental and genetic rat models of ADHD: A pilot study , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[58] C. Barthélémy,et al. Association study of the NF1 gene and autistic disorder. , 1999, American journal of medical genetics.
[59] T. Jessell,et al. A Homeodomain Protein Code Specifies Progenitor Cell Identity and Neuronal Fate in the Ventral Neural Tube , 2000, Cell.
[60] R. Gerlai,et al. Acute and chronic alcohol dose: population differences in behavior and neurochemistry of zebrafish , 2009, Genes, brain, and behavior.
[61] John Struger,et al. Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower Great Lakes, Canada , 2003, Environmental toxicology and chemistry.
[62] D. Barceló,et al. Fate and toxicity of emerging pollutants, their metabolites and transformation products in the aquatic environment , 2008 .
[63] Alejandro J. Ramirez,et al. Enantiospecific sublethal effects of the antidepressant fluoxetine to a model aquatic vertebrate and invertebrate. , 2007, Chemosphere.
[64] D. Barceló,et al. Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. , 2010, Environment international.
[65] P. Mecocci,et al. Interaction of CTSD and A2M polymorphisms in the risk for Alzheimer's disease , 2006, Journal of the Neurological Sciences.
[66] A. Guha,et al. Neurofibromatosis type 1 peripheral nerve tumors: aberrant activation of the Ras pathway. , 1999, Surgical neurology.
[67] P. Anderson,et al. Human pharmaceuticals in US surface waters: a human health risk assessment. , 2005, Regulatory toxicology and pharmacology : RTP.
[68] R. E. Strauss,et al. Behavioural lateralization in zebrafish and four related species of minnows (Osteichthyes: Cyprinidae) , 2010, Animal Behaviour.
[69] Y. Goda,et al. Mechanisms of Synapse Assembly and Disassembly , 2003, Neuron.
[70] Michael A. Thomas,et al. Implications of informatics approaches in ecological research , 2011, Ecol. Informatics.
[71] N. Singewald,et al. Neuroanatomical substrates involved in the anxiogenic-like effect of acute fluoxetine treatment , 2002, Neuropharmacology.
[72] K. Shen,et al. Molecular mechanisms of synaptic specificity , 2010, Molecular and Cellular Neuroscience.
[73] C. Eap,et al. Combination therapy with venlafaxine and carbamazepine in depressive patients not responding to venlafaxine: pharmacokinetic and clinical aspects , 2004, Journal of psychopharmacology.
[74] P. Vourc'h,et al. A functional tetranucleotide (AAAT) polymorphism in an Alu element in the NF1 gene is associated with mental retardation , 2011, Neuroscience Letters.
[75] L. Barber,et al. Predator avoidance performance of larval fathead minnows (Pimephales promelas) following short-term exposure to estrogen mixtures. , 2009, Aquatic toxicology.
[76] Peter J. Brophy,et al. Mechanisms of axon ensheathment and myelin growth , 2005, Nature Reviews Neuroscience.
[77] S. Klaine,et al. Behavioral and biochemical responses of hybrid striped bass during and after fluoxetine exposure. , 2008, Aquatic toxicology.
[78] Jacob Gibs,et al. Efficiency of conventional drinking-water-treatment processes in removal of pharmaceuticals and other organic compounds. , 2007, The Science of the total environment.
[79] Michael Davis,et al. Anxiogenic effects of high illumination levels assessed with the acoustic startle response in rats , 1997, Biological Psychiatry.
[80] T. Ternes. Occurrence of drugs in German sewage treatment plants and rivers 1 Dedicated to Professor Dr. Klaus , 1998 .
[81] C. Hiemke,et al. Pharmacokinetics of selective serotonin reuptake inhibitors. , 2000, Pharmacology & therapeutics.
[82] J. Fetcho,et al. Laser Ablations Reveal Functional Relationships of Segmental Hindbrain Neurons in Zebrafish , 1999, Neuron.
[83] Arnold J. Stromberg,et al. Statistical implications of pooling RNA samples for microarray experiments , 2003, BMC Bioinform..
[84] D. Wong,et al. Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. , 1995, Life sciences.
[85] W. Antonin,et al. Crystal structure of the endosomal SNARE complex reveals common structural principles of all SNAREs , 2002, Nature Structural Biology.
[86] K. Sloman,et al. The effects of environmental pollutants on complex fish behaviour: integrating behavioural and physiological indicators of toxicity. , 2004, Aquatic toxicology.
[87] J. Licinio,et al. Identification of hypothalamic transcripts upregulated by antidepressants. , 1996, Biochemical and biophysical research communications.
[88] Dae-Hyuk Kweon,et al. Regulation of neuronal SNARE assembly by the membrane , 2003, Nature Structural Biology.
[89] P. Jjemba. Excretion and ecotoxicity of pharmaceutical and personal care products in the environment. , 2006, Ecotoxicology and environmental safety.
[90] Giorgio Vallortigara,et al. Origins of the left & right brain. , 2009, Scientific American.
[91] Trevor R. Norman,et al. The treatment of depression with different formulations of venlafaxine: a comparative analysis , 2004, Human psychopharmacology.
[92] S. Chapoval,et al. Biology and function of neuroimmune semaphorins 4A and 4D , 2011, Immunologic research.
[93] B. H. Miller,et al. Genetic Regulation of Behavioral and Neuronal Responses to Fluoxetine , 2008, Neuropsychopharmacology.
[94] S. Hernández-Díaz,et al. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. , 2007, The New England journal of medicine.
[95] Paolo Domenici,et al. Escape behaviour of solitary herring (Clupea harengus ) and comparisons with schooling individuals , 1997 .
[96] C. Maximino,et al. Pharmacological analysis of zebrafish (Danio rerio) scototaxis , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[97] S. Snyder,et al. Toxicological relevance of pharmaceuticals in drinking water. , 2010, Environmental science & technology.
[98] David R. Colman,et al. Molecules, maps and synapse specificity , 2001, Nature Reviews Neuroscience.
[99] Manuel A. R. Ferreira,et al. Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. , 2009, American journal of human genetics.
[100] Diana S Aga,et al. Pharmaceutical metabolites in the environment: Analytical challenges and ecological risks , 2009, Environmental toxicology and chemistry.
[101] D. Guilloteau,et al. Behavior and serotonergic disorders in rats exposed prenatally to valproate: A model for autism , 2010, Neuroscience Letters.
[102] Heiko L Schoenfuss,et al. Antidepressants at environmentally relevant concentrations affect predator avoidance behavior of larval fathead minnows (Pimephales promelas) , 2009, Environmental toxicology and chemistry.
[103] C. de Montigny,et al. Modulation of noradrenergic neuronal firing by selective serotonin reuptake blockers , 1999, British journal of pharmacology.
[104] L. Moens,et al. Neuropharmaceuticals in the environment: Mianserin‐induced neuroendocrine disruption in zebrafish (Danio rerio) using cDNA microarrays , 2006, Environmental toxicology and chemistry.
[105] R. Gerlai,et al. Drinks like a fish: zebra fish (Danio rerio) as a behavior genetic model to study alcohol effects , 2000, Pharmacology Biochemistry and Behavior.
[106] J. Santos,et al. Presence of pharmaceutically active compounds in Doñana Park (Spain) main watersheds. , 2010, Journal of hazardous materials.
[107] Anders Baun,et al. Probabilistic environmental risk characterization of pharmaceuticals in sewage treatment plant discharges. , 2009, Chemosphere.
[108] D. Neary,et al. Genetic associations between cathepsin D exon 2 C→T polymorphism and Alzheimer’s disease, and pathological correlations with genotype , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[109] Yu-Ming Chang,et al. Increased action potential firing rates of layer 2/3 pyramidal cells in the prefrontal cortex are significantly related to cognitive performance in aged monkeys. , 2005, Cerebral cortex.
[110] K. Borowicz,et al. Fluoxetine enhances the anticonvulsant effects of conventional antiepileptic drugs in maximal electroshock seizures in mice. , 2006, Pharmacological reports : PR.
[111] G. Augustine,et al. SNARE proteins and the timing of neurotransmitter release , 1998, Molecular Psychiatry.
[112] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[113] Y. Fujiyoshi,et al. Dual inhibition of SNARE complex formation by tomosyn ensures controlled neurotransmitter release , 2008, The Journal of cell biology.
[114] Lincoln Stein,et al. Reactome: a database of reactions, pathways and biological processes , 2010, Nucleic Acids Res..
[115] Dalma Martinović,et al. Environmental estrogens suppress hormones, behavior, and reproductive fitness in male fathead minnows , 2007, Environmental toxicology and chemistry.
[116] Kevin Dobbin,et al. Effects of pooling mRNA in microarray class comparisons , 2004, Bioinform..
[117] F. Panza,et al. The cathepsin D gene exon 2 (C224T) polymorphism and sporadic Alzheimer's disease in European populations. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.